AstraZeneca said on Friday its and Daiichi Sankyo's cancer drug Enhertu was recommended by the European Medicines Agency's human medicines committee as a monotherapy to treat patients with a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback